1. Home
  2. GETY vs PHAT Comparison

GETY vs PHAT Comparison

Compare GETY & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GETY
  • PHAT
  • Stock Information
  • Founded
  • GETY 1995
  • PHAT 2018
  • Country
  • GETY United States
  • PHAT United States
  • Employees
  • GETY N/A
  • PHAT N/A
  • Industry
  • GETY Industrial Machinery/Components
  • PHAT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GETY Industrials
  • PHAT Health Care
  • Exchange
  • GETY Nasdaq
  • PHAT Nasdaq
  • Market Cap
  • GETY 723.5M
  • PHAT 727.5M
  • IPO Year
  • GETY N/A
  • PHAT 2019
  • Fundamental
  • Price
  • GETY $1.78
  • PHAT $8.91
  • Analyst Decision
  • GETY Hold
  • PHAT Strong Buy
  • Analyst Count
  • GETY 5
  • PHAT 5
  • Target Price
  • GETY $4.35
  • PHAT $16.40
  • AVG Volume (30 Days)
  • GETY 1.3M
  • PHAT 5.0M
  • Earning Date
  • GETY 08-08-2025
  • PHAT 08-07-2025
  • Dividend Yield
  • GETY N/A
  • PHAT N/A
  • EPS Growth
  • GETY N/A
  • PHAT N/A
  • EPS
  • GETY N/A
  • PHAT N/A
  • Revenue
  • GETY $941,086,000.00
  • PHAT $81,859,000.00
  • Revenue This Year
  • GETY $2.71
  • PHAT $195.45
  • Revenue Next Year
  • GETY $2.74
  • PHAT $106.76
  • P/E Ratio
  • GETY N/A
  • PHAT N/A
  • Revenue Growth
  • GETY 4.20
  • PHAT 3055.70
  • 52 Week Low
  • GETY $1.25
  • PHAT $2.21
  • 52 Week High
  • GETY $4.49
  • PHAT $19.71
  • Technical
  • Relative Strength Index (RSI)
  • GETY 49.69
  • PHAT 53.97
  • Support Level
  • GETY $1.60
  • PHAT $8.72
  • Resistance Level
  • GETY $1.78
  • PHAT $10.13
  • Average True Range (ATR)
  • GETY 0.09
  • PHAT 0.81
  • MACD
  • GETY -0.00
  • PHAT -0.33
  • Stochastic Oscillator
  • GETY 43.55
  • PHAT 3.96

About GETY Getty Images Holdings Inc.

Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: